|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.15 USD | -0.22% |
|
+3.85% | -1.75% |
| Oct. 25 | Tranche Update on Balchem Corporation's Equity Buyback Plan announced on August 6, 1999. | CI |
| Oct. 25 | Balchem Corporation, Q3 2024 Earnings Call, Oct 25, 2024 |
| Capitalization | 5.21B 5.06B 4.76B 4.27B 7.5B 451B 8.38B 58.12B 21.53B 185B 19.52B 19.12B 814B | P/E ratio 2024 * |
40.2x | P/E ratio 2025 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise value | 5.34B 5.19B 4.88B 4.38B 7.69B 462B 8.59B 59.59B 22.08B 190B 20.02B 19.61B 834B | EV / Sales 2024 * |
5.6x | EV / Sales 2025 * | 5.1x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Balchem Corporation
More recommendations
More press releases
| 1 day | -0.22% | ||
| 1 week | +3.85% | ||
| Current month | -1.75% | ||
| 1 month | -3.82% | ||
| 3 months | -6.10% | ||
| 6 months | -7.13% | ||
| Current year | -1.75% |
1 week
156.48
162.32
1 month
152.60169.29
Current year
152.60163.32
1 year
137.69186.03
3 years
110.15186.03
5 years
78.30186.03
10 years
50.81186.03
| Director | Title | Age | Since |
|---|---|---|---|
Theodore Harris
CEO | Chief Executive Officer | 60 | 2015-04-27 |
Martin Bengtsson
DFI | Director of Finance/CFO | 48 | 2019-02-03 |
Michael Sestrick
CTO | Chief Tech/Sci/R&D Officer | 62 | 2016-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Fischer
BRD | Director/Board Member | 62 | 2010-09-15 |
Theodore Harris
CHM | Chairman | 60 | 2016-12-31 |
| Director/Board Member | 58 | 2015-09-14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.90% | 0 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.22% | +3.85% | +13.53% | +6.28% | 5.21B | ||
| -0.72% | +3.35% | +18.79% | +10.53% | 67.23B | ||
| +0.67% | +1.85% | +17.63% | -5.58% | 39.67B | ||
| +1.25% | +4.65% | -1.94% | -32.19% | 39.42B | ||
| +0.46% | -0.66% | +6.59% | +25.18% | 25.27B | ||
| +0.40% | +3.34% | -1.63% | -34.77% | 16.17B | ||
| +0.83% | -0.24% | +5.25% | -14.09% | 14.18B | ||
| +1.71% | +0.47% | +19.93% | +51.82% | 11.8B | ||
| +0.30% | +4.67% | -16.12% | -30.12% | 11.47B | ||
| +3.36% | +12.67% | -15.32% | -55.62% | 11.46B | ||
| Average | +0.80% | +2.83% | +4.67% | -7.86% | 24.19B | |
| Weighted average by Cap. | +0.48% | +2.44% | +8.46% | -5.16% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 954M 927M 872M 782M 1.37B 82.57B 1.53B 10.65B 3.94B 33.91B 3.58B 3.5B 149B | 1.02B 987M 929M 834M 1.46B 87.99B 1.64B 11.34B 4.2B 36.14B 3.81B 3.73B 159B |
| Net income | 131M 127M 120M 108M 189M 11.36B 211M 1.46B 542M 4.66B 492M 482M 20.5B | 152M 147M 139M 124M 218M 13.12B 244M 1.69B 627M 5.39B 568M 557M 23.69B |
| Net Debt | 132M 128M 121M 108M 190M 11.43B 212M 1.47B 546M 4.69B 495M 485M 20.63B | -26.64M -25.89M -24.35M -21.85M -38.38M -2.31B -42.87M -297M -110M -947M -99.91M -97.86M -4.16B |
More financial data
* Estimated data
Employees
1,300
Sector
Specialty Chemicals
Calendar
2025-02-13
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-17 | 160.15 $ | -0.22% | 126,794 |
| 25-01-16 | 160.51 $ | +0.21% | 120,144 |
| 25-01-15 | 160.18 $ | +0.98% | 141,851 |
| 25-01-14 | 158.62 $ | +1.46% | 108,072 |
| 25-01-13 | 156.33 $ | +1.37% | 120,970 |
Delayed Quote Nasdaq, January 17, 2025 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
160.15USD
Average target price
190.33USD
Spread / Average Target
+18.85%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BCPC Stock